CAMPOCHIARO, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 1.729
AS - Asia 1.239
EU - Europa 1.114
SA - Sud America 242
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.347
Nazione #
US - Stati Uniti d'America 1.665
SG - Singapore 528
RO - Romania 435
CN - Cina 382
IT - Italia 226
BR - Brasile 197
HK - Hong Kong 141
DE - Germania 108
VN - Vietnam 75
SE - Svezia 58
GB - Regno Unito 49
CA - Canada 41
FI - Finlandia 40
RU - Federazione Russa 34
FR - Francia 33
AT - Austria 26
IN - India 26
JP - Giappone 23
ES - Italia 22
NL - Olanda 22
PL - Polonia 22
MX - Messico 19
AR - Argentina 18
ZA - Sudafrica 14
LT - Lituania 13
BD - Bangladesh 12
KR - Corea 8
TR - Turchia 8
EC - Ecuador 7
PY - Paraguay 7
UZ - Uzbekistan 7
ID - Indonesia 6
NO - Norvegia 6
AE - Emirati Arabi Uniti 5
LU - Lussemburgo 5
PK - Pakistan 5
CL - Cile 4
VE - Venezuela 4
CO - Colombia 3
IE - Irlanda 3
IQ - Iraq 3
PT - Portogallo 3
TN - Tunisia 3
UA - Ucraina 3
DO - Repubblica Dominicana 2
EG - Egitto 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
MA - Marocco 1
MD - Moldavia 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 4.347
Città #
Dallas 930
Singapore 293
Ashburn 143
Hong Kong 136
Beijing 85
Shanghai 78
Milan 63
Los Angeles 61
Hefei 58
New York 56
Munich 39
Boardman 36
Nuremberg 31
Ho Chi Minh City 27
Denver 22
Tokyo 21
São Paulo 19
Brooklyn 17
Poplar 17
Warsaw 17
Montreal 16
Santa Clara 16
Helsinki 15
Phoenix 14
Stockholm 14
Amsterdam 13
Johannesburg 13
Moscow 13
Rome 13
Turku 13
Falkenstein 12
Guangzhou 12
Lappeenranta 12
Chennai 11
Chicago 11
Atlanta 10
Frankfurt am Main 10
Hanoi 10
Houston 10
Toronto 10
Boston 9
Rio de Janeiro 9
Ankara 8
Lawrence 8
London 8
Naples 8
Princeton 8
Seongnam-si 8
Vaprio d'Adda 8
Vienna 8
Buffalo 7
Cesano Boscone 7
Mugnano di Napoli 7
Secaucus 7
Tashkent 7
Xi'an 7
Bergamo 6
Orem 6
Oslo 6
Querétaro 6
St Louis 6
Ancona 5
Cagliari 5
City of London 5
Esch-sur-Alzette 5
Kassel 5
Mexico City 5
Porto Alegre 5
Shenzhen 5
Belo Horizonte 4
Da Nang 4
Haiphong 4
Quito 4
Romagnano Sesia 4
Roubaix 4
San Jose 4
Segrate 4
The Dalles 4
Turin 4
Alessandria 3
Amadora 3
Angera 3
Annapolis 3
Asunción 3
Augusta 3
Bexley 3
Brasília 3
Brescia 3
Campos dos Goytacazes 3
Charleston 3
Fortaleza 3
Hangzhou 3
Hải Dương 3
Mumbai 3
New Delhi 3
Oklahoma City 3
Osimo 3
Ottawa 3
Pune 3
Recife 3
Totale 2.694
Nome #
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 421
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 382
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 320
Monkeypox in a patient with undifferentiated connective tissue disease 217
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 94
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 83
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 82
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 81
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 78
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 77
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 76
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 74
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 72
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 71
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 69
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 67
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 67
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 67
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 66
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 66
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 65
Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down 64
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 64
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 63
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 63
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 63
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 62
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 62
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 62
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 60
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 59
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 58
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 58
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 56
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 54
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 53
VEXAS associated acute disseminated Encephalo-Myelitis (ADEM)-like syndrome: A case report and review of the literature 53
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 53
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 52
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 51
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 50
Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation 50
HETEROGENEITY OF CYTOPENIAS IN VEXAS SYNDROME: A SINGLE CENTRE EXPERIENCE 49
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 44
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine 43
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 42
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 39
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981) 38
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 36
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 33
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review 33
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 33
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 31
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis 29
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review 29
Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight 28
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review 27
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 26
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 25
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis? 25
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 4
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational study 2
Totale 4.554
Categoria #
all - tutte 18.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 2 0 0 1 0 2 1
2021/202231 0 0 3 3 1 8 2 2 5 3 2 2
2022/2023109 19 16 9 0 0 13 28 14 4 0 5 1
2023/2024314 4 13 15 30 25 48 38 38 3 18 28 54
2024/20251.457 55 14 39 62 54 89 585 114 132 90 90 133
2025/20262.631 304 608 673 539 392 115 0 0 0 0 0 0
Totale 4.554